Screener
AngioDynamics ANGO Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | May 31, 2026 | May 31, 2025 |
|---|---|---|
| Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, par value $0.01 per share, 75,000,000 shares authorized; 42,314,266 and 41,607,877 shares issued and 41,700,419 and 40,994,030 shares outstanding at May 31, 2026 and 2025, respectively | 387 | 385 |
| Additional paid-in capital | 636,083 | 621,186 |
| Accumulated deficit | (465,939) | (429,197) |
| Treasury stock, 613,847 shares, at cost at May 31, 2026 and 2025, respectively | (7,381) | (7,381) |
| Accumulated other comprehensive loss | 7,675 | (2,023) |
| Total Stockholders' Equity | 170,825 | 182,970 |
| Total Liabilities and Stockholders' Equity | $267,163 | $280,144 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's total equity?
- AngioDynamics (ANGO) reported total equity of $170.83M in Q1 2026.
- How has AngioDynamics's total equity changed year-over-year?
- AngioDynamics's total equity decreased by 6.6% year-over-year, from $182.97M to $170.83M.
- What is the long-term trend for AngioDynamics's total equity?
- Over 5 years (2021 to 2026), AngioDynamics's total equity has grown at a -17.2% compound annual growth rate (CAGR), from $439.46M to $170.83M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about AngioDynamics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude